Anticoagulants in atrial fibrillation patients with chronic kidney disease

Abstract

Atrial fibrillation is an important cause of preventable, disabling stroke and is particularly frequent in patients with chronic kidney disease (CKD). Stage 3 CKD is an independent risk factor for stroke in patients with atrial fibrillation. Warfarin anticoagulation is efficacious for stroke prevention in atrial fibrillation patients with stage 3 CKD, but… (More)
DOI: 10.1038/nrneph.2012.160

Topics

8 Figures and Tables

Cite this paper

@article{Hart2012AnticoagulantsIA, title={Anticoagulants in atrial fibrillation patients with chronic kidney disease}, author={Robert G. Hart and John W. Eikelboom and Alistair J. Ingram and Charles A. Herzog}, journal={Nature Reviews Nephrology}, year={2012}, volume={8}, pages={569-578} }